U.S. flag

An official website of the United States government

NM_003001.5(SDHC):c.175del (p.Tyr59fs) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 17, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001233063.8

Allele description [Variation Report for NM_003001.5(SDHC):c.175del (p.Tyr59fs)]

NM_003001.5(SDHC):c.175del (p.Tyr59fs)

Gene:
SDHC:succinate dehydrogenase complex subunit C [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
1q23.3
Genomic location:
Preferred name:
NM_003001.5(SDHC):c.175del (p.Tyr59fs)
HGVS:
  • NC_000001.11:g.161328493del
  • NG_012767.1:g.19118del
  • NM_001035511.3:c.175del
  • NM_001035512.3:c.77+4823del
  • NM_001035513.3:c.21-12101del
  • NM_001278172.3:c.77+4823del
  • NM_001407115.1:c.175del
  • NM_001407116.1:c.118del
  • NM_001407117.1:c.118del
  • NM_001407118.1:c.77+4823del
  • NM_001407119.1:c.64del
  • NM_001407120.1:c.64del
  • NM_001407121.1:c.118del
  • NM_003001.5:c.175delMANE SELECT
  • NP_001030588.1:p.Tyr59fs
  • NP_001394044.1:p.Tyr59fs
  • NP_001394045.1:p.Tyr40fs
  • NP_001394046.1:p.Tyr40fs
  • NP_001394048.1:p.Tyr22fs
  • NP_001394049.1:p.Tyr22fs
  • NP_001394050.1:p.Tyr40fs
  • NP_002992.1:p.Tyr59Thrfs
  • NP_002992.1:p.Tyr59fs
  • LRG_317t1:c.175del
  • LRG_317:g.19118del
  • NC_000001.10:g.161298283del
  • NM_003001.3:c.175del
  • NM_003001.3:c.175delT
  • NR_103459.3:n.200del
Protein change:
Y22fs
Links:
dbSNP: rs1671157149
NCBI 1000 Genomes Browser:
rs1671157149
Molecular consequence:
  • NM_001035511.3:c.175del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407115.1:c.175del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407116.1:c.118del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407117.1:c.118del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407119.1:c.64del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407120.1:c.64del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001407121.1:c.118del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_003001.5:c.175del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001035512.3:c.77+4823del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001035513.3:c.21-12101del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001278172.3:c.77+4823del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001407118.1:c.77+4823del - intron variant - [Sequence Ontology: SO:0001627]
  • NR_103459.3:n.200del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Gastrointestinal stromal tumor
Synonyms:
Gastrointestinal Stromal Sarcoma; Gastrointestinal stromal tumor, somatic; Gastrointestinal stroma tumor
Identifiers:
MONDO: MONDO:0011719; MeSH: D046152; MedGen: C0238198; Orphanet: 44890; OMIM: 606764; Human Phenotype Ontology: HP:0100723
Name:
Paragangliomas 3 (PPGL3)
Synonyms:
Glomus tumors, familial, 3; SDHC-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome (Paragangliomas 3); PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 3
Identifiers:
MONDO: MONDO:0011544; MedGen: C1854336; Orphanet: 29072; OMIM: 605373

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001405642Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 17, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.

Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, Niccoli P, Gaillard D, Chabrier G, Chabolle F, Coupier I, Thieblot P, Lecomte P, Bertherat J, Wion-Barbot N, Murat A, Venisse A, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP; PGL.NET network..

J Clin Endocrinol Metab. 2009 Aug;94(8):2817-27. doi: 10.1210/jc.2008-2504. Epub 2009 May 19.

PubMed [citation]
PMID:
19454582

The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).

Else T, Marvin ML, Everett JN, Gruber SB, Arts HA, Stoffel EM, Auchus RJ, Raymond VM.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1482-6. doi: 10.1210/jc.2013-3853. Epub 2014 Apr 23.

PubMed [citation]
PMID:
24758179
PMCID:
PMC4121019
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001405642.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SDHC are known to be pathogenic (PMID: 19454582, 24758179). This variant has not been reported in the literature in individuals with SDHC-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Tyr59Thrfs*20) in the SDHC gene. It is expected to result in an absent or disrupted protein product.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024